Adhikari Prashant, Amatya Isha, Regmi Pradeep, Sharma Jeevan Kumar, Pangeni Raju, Pokharel Nishma, Bhatta Smriti, Shrestha Deepak, Pant Bhaskar Raj, Bhandari Sandeep, Dhakal Arun, Karaikovic Eldin, Acaroğlu Emre
Hospital for Advanced Medicine and Surgery (HAMS), Kathmandu, Nepal.
Patan Academy of Health Sciences, Patan, Nepal.
Eur Spine J. 2025 Sep 1. doi: 10.1007/s00586-025-09315-9.
Spinal tuberculosis (STB) remains prevalent in developing nations and significantly contributes to morbidity, often resulting in kyphotic deformity and neurological deficits. In this study, we correlate the diagnostic, therapeutic and prognostic factors according to the current standard of management of STB.
This retrospective study evaluated diagnostic and prognostic factors in 77 patients with STB treated surgically (37.7%) or non-surgically (62.3%) between 2018 and 2023. Diagnostic tools included GeneXpert MTB/RIF(GXMTB/RIF)- a rapid molecular test for detecting Mycobacterium tuberculosis and rifampicin resistance- and histopathological confirmation via biopsy. Clinical outcomes were assessed using Visual Analogue Scale, Oswestry Disability Index, inflammatory markers (ESR, CRP), kyphotic deformity correction, and neurological improvement.
GeneXpert MTB/RIF detected Mycobacterium tuberculosis in 94.8% of cases, with 5.2% showing rifampicin resistance. Histopathology revealed granulomatous infiltration in 96.1% of biopsies, underscoring the importance of combining diagnostic methods. Both groups showed significant improvement over 12 months, with surgical patients exhibiting higher baseline kyphosis angles (47.41° vs. 19.27°, p < 0.001) and greater post-treatment correction (14.14° vs. 2.71°, p = 0.04). Neurological status, evaluated via ASIA Impairment Scale improved post-treatment, with 93.5% achieving normal neurology. Deformity presence strongly correlated with surgical intervention (51.9% vs. 8%, p < 0.001).
The study highlights the efficacy of anti-tubercular therapy (ATT) and the role of surgery in severe deformity or neurological compromise. Notably, rare discrepancies between GXMTB/RIF and histopathology (5.2% GXMTB/RIF - negative but histopathology- positive) emphasize the need for clinical judgment alongside laboratory findings. Surgical intervention is pivotal for deformity correction and neurological recovery, while ATT remains the cornerstone.
脊柱结核(STB)在发展中国家仍然普遍存在,并且是导致发病的重要因素,常导致脊柱后凸畸形和神经功能缺损。在本研究中,我们根据当前STB的治疗标准,对其诊断、治疗和预后因素进行相关性分析。
这项回顾性研究评估了2018年至2023年间77例接受手术治疗(37.7%)或非手术治疗(62.3%)的STB患者的诊断和预后因素。诊断工具包括GeneXpert MTB/RIF(GXMTB/RIF)——一种用于检测结核分枝杆菌和利福平耐药性的快速分子检测方法,以及通过活检进行组织病理学确诊。使用视觉模拟量表、Oswestry功能障碍指数、炎症标志物(血沉、C反应蛋白)、脊柱后凸畸形矫正情况和神经功能改善情况来评估临床结果。
GeneXpert MTB/RIF在94.8%的病例中检测到结核分枝杆菌,5.2%显示利福平耐药。组织病理学显示96.1%的活检中有肉芽肿浸润,突出了联合诊断方法的重要性。两组在12个月内均有显著改善,手术患者的基线脊柱后凸角度更高(47.41°对19.27°,p < 0.001),治疗后矫正幅度更大(14.14°对2.71°,p = 0.04)。通过美国脊髓损伤协会损伤量表评估的神经功能在治疗后有所改善,93.5%的患者神经功能恢复正常。畸形的存在与手术干预密切相关(51.9%对8%,p < 0.001)。
该研究突出了抗结核治疗(ATT)的疗效以及手术在严重畸形或神经功能损害中的作用。值得注意的是,GXMTB/RIF与组织病理学之间存在罕见差异(5.2%的病例GXMTB/RIF阴性但组织病理学阳性),这强调了除实验室检查结果外还需要临床判断。手术干预对于畸形矫正和神经功能恢复至关重要,而ATT仍然是基石。